Collegium to Participate in Upcoming Investor Conferences
November 26, 2019 08:01 ET
|
Collegium Pharmaceutical, Inc.
STOUGHTON, Mass., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
Collegium to Participate in Upcoming Investor Conference
November 08, 2019 08:00 ET
|
Collegium Pharmaceutical, Inc.
STOUGHTON, Mass., Nov. 08, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
Collegium Reports Third Quarter 2019 Financial Results
November 06, 2019 16:01 ET
|
Collegium Pharmaceutical, Inc.
– New Exclusive Formulary Wins Announced for Xtampza® ER Effective January 1, 2020 Covering More than 35 Million Lives – – Xtampza® ER Net Product Revenues Were $26.5 Million in the Third Quarter of...
Collegium to Host Conference Call to Discuss Third Quarter 2019 Financial Results and Provide Corporate Update
October 23, 2019 08:00 ET
|
Collegium Pharmaceutical, Inc.
STOUGHTON, Mass., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday,...
Collegium to Participate in Upcoming Investor Conference
September 25, 2019 08:00 ET
|
Collegium Pharmaceutical, Inc.
STOUGHTON, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
Collegium to Participate in Upcoming Investor Conferences
September 03, 2019 16:01 ET
|
Collegium Pharmaceutical, Inc.
STOUGHTON, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
Collegium Announces Scientific Presentations at PAINWeek 2019 National Conference
August 29, 2019 16:01 ET
|
Collegium Pharmaceutical, Inc.
STOUGHTON, Mass., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
Collegium Reports Second Quarter 2019 Financial Results
August 07, 2019 16:01 ET
|
Collegium Pharmaceutical, Inc.
– Xtampza® ER Net Product Revenues Were $26.0 Million in the Second Quarter of 2019, a 44% Increase Over the Second Quarter of 2018 – – Cash and Cash Equivalents Increased to $148.7 Million as of...
Collegium to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Provide Corporate Update
July 24, 2019 16:01 ET
|
Collegium Pharmaceutical, Inc.
STOUGHTON, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday,...
Collegium to Present at Upcoming Investor Conferences
May 29, 2019 08:00 ET
|
Collegium Pharmaceutical, Inc.
STOUGHTON, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...